They consist of an oral or subcutaneous administration of pharmacoactive drugs involved in hypertension (namely angiotensin II (Ag II), deoxycorticosterone acetate (DOCA), and N-nitro-L-arginine methyl ester (L-NAME)), with the duration of treatment depending on the severity of hypertension that is targeted. This evidence concerns the gene AGT and Hypertension.